To date, no studies have evaluated these mutations in the Brazilian population, therefore the aim of the present study was to evaluate the prevalence of TERT promoter mutations in head and neck cancer patients in Brazil and evaluate for associations with outcome. The gene discussed is TERT; the disease is head and neck cancer.